NFKB1 and brain ischemia: Research has indicated that tanshinone IIA has the potential to modulate the TLR4/NF-κB p65 signaling pathway, enhancing oxidative stress levels to address hypoxic/ischemic encephalopathy (Fang et al., 2018b).